Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
NRSInsights’ March 2024 Retail Same-Store Sales Report
-
Convocation of the ordinary general shareholders meeting of Invalda INVL
-
ROSEN, A LEADING LAW FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL
-
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Checkpoint Therapeutics, Inc. (CKPT) Investors
-
ROSEN, A TOP RANKED LAW FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTYX
-
Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing
-
NOTICE TO DISREGARD -- LeaseQuery
-
Believe It or Not! Total Solar Eclipse Captured for Ripley’s Exhibit Collection
-
Verita announces claims leadership team
-
Onco360 Has Been Selected as the Sole National Specialty Pharmacy Partner for Voydeya® (danicopan)
-
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024
-
Team, Inc. Appoints Pamela J. McGinnis to Its Board of Directors
-
Angi Appoints Jeff Kip as CEO
-
Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology Platform
-
Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference
-
Chart Industries Announces Amended Revolving Credit Facility
-
Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting
-
Interpublic Schedules First Quarter 2024 Earnings Release
-
iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting
-
QuoteMedia Announces 8% Revenue Growth for 2023
-
Looking for More? CheapOair Shares Round Up of Future Eclipse Events
-
HUT DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages Hut 8 Corp. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action – HUT
-
Peapack Private Announces New York City Expansion
-
ROSEN, A LONGSTANDING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BLUE
-
Allbirds Receives Notice of Non-Compliance with Nasdaq Minimum Bid Price Requirement
-
Gildan Activewear Announces Investor Update on April 15, 2024
-
American Assets Trust, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call Information
-
Norwegian Cruise Line Holdings Unveils Bold New Vision for the Future with Strategic Long Term Fleet Expansion and Enhanced Private Island Development
-
Delisting of Securities of NanoString Technologies, Inc.; Remark Holdings, Inc.; Sunworks, Inc.; Cyanotech Corporation; Sientra, Inc.; Atlantic Coastal Acquisition Corp.; Charge Enterprises, Inc.; Sag
-
Matthews International Announces Second Quarter Fiscal 2024 Earnings Release and Conference Call
-
Casella Waste Systems, Inc. to Host Conference Call on Its First Quarter 2024 Results and to Present at an Upcoming Investor Event
-
IBEX Completes Sale of the Company
-
Appian to Host Investor Day at Appian World on April 16
-
Sonoco and ENGIE Announce 140 Megawatt Virtual Power Purchase Agreement – Output from Big Sampson Wind Project will be First Renewable Energy Project for Sonoco
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages The Chemours Company Investors to Secure Counsel Before Important Deadline in Securities Class Action – CC
-
MODN Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Model N to Vista Equity Partners
-
MODN Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Model N to Vista Equity Partners
-
ThredUp to Report First Quarter 2024 Financial Results on May 6, 2024
-
CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
-
Methode Electronics Announces CFO Transition Plan
-
Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study
-
NN, Inc. Announces Another Strong Quarter of New Business Awards at $17.2 million in Q1 2024
-
HeartCore Reports Full Year 2023 Results and Provides Strategic Priorities for 2024
-
WEYCO Group, Inc. First Quarter 2024 Earnings Conference Call
-
Magnite to Announce First Quarter 2024 Financial Results on May 8, 2024
-
Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights
-
TEN Ltd. Declares Dividend on its Series F Cumulative Redeemable Perpetual Preferred Shares
-
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
-
Mondelēz International to Report Q1 2024 Financial Results on April 30, 2024
-
Tenable Recognized as a Cyber AI Leader on the First-Ever CRN AI 100 List

